KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 126 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 1.12 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $388,000 | -67.2% | 83,386 | -50.0% | 0.01% | -43.5% |
| Q3 2017 | $1,184,000 | +245.2% | 166,772 | +385.1% | 0.02% | +9.5% |
| Q2 2015 | $343,000 | -68.1% | 34,380 | -59.3% | 0.02% | -74.7% |
| Q1 2015 | $1,074,000 | -62.0% | 84,380 | -57.8% | 0.08% | -65.0% |
| Q4 2014 | $2,830,000 | +2.9% | 200,000 | 0.0% | 0.24% | -19.7% |
| Q3 2014 | $2,750,000 | -41.3% | 200,000 | -27.3% | 0.30% | -40.0% |
| Q1 2014 | $4,686,000 | +16.1% | 275,000 | -31.2% | 0.49% | +196.4% |
| Q3 2013 | $4,036,000 | +979.1% | 400,000 | +700.0% | 0.17% | +336.8% |
| Q2 2013 | $374,000 | – | 50,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management I, LLC | 1,312,006 | $16,990,000 | 16.50% |
| VHCP Management, LLC | 1,000,273 | $12,954,000 | 6.97% |
| Cormorant Asset Management, LP | 1,700,000 | $22,015,000 | 6.39% |
| HARVEY CAPITAL MANAGEMENT INC | 890,500 | $11,531,000 | 4.76% |
| INSIGHT CAPITAL RESEARCH & MANAGEMENT INC | 859,672 | $11,133,000 | 2.50% |
| Rhenman & Partners Asset Management AB | 400,000 | $5,180,000 | 2.03% |
| SECTORAL ASSET MANAGEMENT INC | 2,758,950 | $35,728,000 | 1.54% |
| NORTHPOINTE CAPITAL LLC | 1,289,711 | $16,701,000 | 1.47% |
| Knoll Capital Management, LLC | 200,000 | $2,592,000 | 1.30% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,483,260 | $19,208,000 | 1.00% |